Compugen (CGEN) News Today $1.64 -0.07 (-4.09%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Short Interest in Compugen Ltd. (NASDAQ:CGEN) Decreases By 17.1%Compugen Ltd. (NASDAQ:CGEN - Get Free Report) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totalling 1,550,000 shares, a decrease of 17.1% from the September 30th total of 1,870,000 shares. Based on an average daily trading volume, of 231,800 shares, the short-interest ratio is currently 6.7 days.October 29, 2024 | marketbeat.comCompugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024October 29, 2024 | prnewswire.comCompugen to Present New Clinical Data at SITC 2024October 7, 2024 | prnewswire.comBiomerica (NASDAQ:BMRA) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comCompugen Ltd. (NASDAQ:CGEN) Sees Large Growth in Short InterestCompugen Ltd. (NASDAQ:CGEN - Get Free Report) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 1,880,000 shares, a growth of 15.3% from the August 31st total of 1,630,000 shares. Based on an average daily volume of 256,200 shares, the days-to-cover ratio is currently 7.3 days.September 29, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Short Interest Down 5.8% in AugustCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 1,630,000 shares, a decrease of 5.8% from the August 15th total of 1,730,000 shares. Based on an average trading volume of 266,200 shares, the short-interest ratio is currently 6.1 days.September 18, 2024 | marketbeat.comGSK, iTeos lung cancer therapy outperforms Jemperli in mid-stage trialSeptember 14, 2024 | msn.comCompugen to Present at Single Cell Genomics 2024 ConferenceSeptember 9, 2024 | prnewswire.comCompugen to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 29, 2024 | prnewswire.comCompugen LtdAugust 27, 2024 | money.usnews.comTruist Financial Keeps Their Buy Rating on Compugen (CGEN)August 16, 2024 | markets.businessinsider.comCompugen (NASDAQ:CGEN) Lifted to "Buy" at StockNews.comStockNews.com upgraded shares of Compugen from a "hold" rating to a "buy" rating in a report on Thursday.August 15, 2024 | marketbeat.comCompugen Ltd. (CGEN)August 13, 2024 | finance.yahoo.comParty Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings ForecastsAugust 11, 2024 | finance.yahoo.comCompugen Ltd. (CGEN) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comCompugen: Strong Buy on Promising Trials, Strategic Alliances, and Solid FinancialsAugust 9, 2024 | markets.businessinsider.comCompugen (NASDAQ:CGEN) Cut to Hold at StockNews.comStockNews.com cut shares of Compugen from a "buy" rating to a "hold" rating in a research report on Wednesday.August 7, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN): When Will It Breakeven?August 7, 2024 | finance.yahoo.comCompugen Reports Second Quarter 2024 ResultsAugust 6, 2024 | prnewswire.comCompugen Q2 2024 Earnings PreviewAugust 6, 2024 | msn.comCheckpoint Therapeutics (NASDAQ:CKPT) Stock Quotes, Forecast and News SummaryJuly 31, 2024 | benzinga.comCompugen (CGEN) Scheduled to Post Quarterly Earnings on TuesdayCompugen (NASDAQ:CGEN) will be releasing earnings before the market opens on Tuesday, August 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=611417)July 30, 2024 | marketbeat.comCompugen Ltd.: Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid TumorsJuly 29, 2024 | finanznachrichten.deCompugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid TumorsJuly 29, 2024 | prnewswire.comStifel Nicolaus Keeps Their Buy Rating on Compugen (CGEN)July 23, 2024 | markets.businessinsider.comCompugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024July 23, 2024 | prnewswire.comStockNews.com Upgrades Compugen (NASDAQ:CGEN) to "Buy"StockNews.com raised Compugen from a "hold" rating to a "buy" rating in a research note on Wednesday.June 19, 2024 | marketbeat.comCompugen to Present at Upcoming Antibody Industrial SymposiumJune 17, 2024 | prnewswire.comStockNews.com Lowers Compugen (NASDAQ:CGEN) to HoldStockNews.com cut Compugen from a "buy" rating to a "hold" rating in a research note on Tuesday.June 11, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Sees Significant Decrease in Short InterestCompugen Ltd. (NASDAQ:CGEN - Get Free Report) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,730,000 shares, a decrease of 11.3% from the April 30th total of 1,950,000 shares. Based on an average daily trading volume, of 517,200 shares, the days-to-cover ratio is presently 3.3 days.June 2, 2024 | marketbeat.comCompugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating RilvegostomigMay 30, 2024 | prnewswire.comCompugen’s Strategic Shift to PROC Program Merits a Buy RatingMay 22, 2024 | markets.businessinsider.comEarnings Release: Here's Why Analysts Cut Their Compugen Ltd. (NASDAQ:CGEN) Price Target To US$5.00May 22, 2024 | finance.yahoo.comCompugen (NASDAQ:CGEN) Upgraded at StockNews.comStockNews.com raised shares of Compugen from a "hold" rating to a "buy" rating in a report on Tuesday.May 22, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Q1 2024 Earnings Call TranscriptMay 21, 2024 | msn.comTruist Financial Cuts Compugen (NASDAQ:CGEN) Price Target to $4.00Truist Financial cut their price target on Compugen from $5.00 to $4.00 and set a "buy" rating for the company in a report on Tuesday.May 21, 2024 | marketbeat.comCompugen Ltd.: Compugen Reports First Quarter 2024 ResultsMay 20, 2024 | finanznachrichten.deCGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024May 20, 2024 | investorplace.comCompugen Reports First Quarter 2024 ResultsMay 20, 2024 | prnewswire.comCompugen Q1 2024 Earnings PreviewMay 17, 2024 | msn.comCompugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic PotentialMay 16, 2024 | prnewswire.comCompugen Ltd.: Compugen Appoints David Silberman as Chief Financial OfficerMay 15, 2024 | finanznachrichten.deCompugen Names David Silberman Chief Financial OfficerMay 15, 2024 | marketwatch.comCompugen Appoints David Silberman as Chief Financial OfficerMay 15, 2024 | prnewswire.com3 Biotech Stocks to Monitor for May MovesMay 14, 2024 | stocknews.comCompugen to Release First Quarter 2024 Results on Monday, May 20, 2024May 6, 2024 | prnewswire.comWe're Not Worried About Compugen's (NASDAQ:CGEN) Cash BurnApril 29, 2024 | finance.yahoo.comCompugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024April 25, 2024 | prnewswire.com3 Biotech Stocks with Potential Gains - Watch or Buy?April 15, 2024 | stocknews.comCompugen Ltd. (NASDAQ:CGEN) Sees Significant Increase in Short InterestCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 2,090,000 shares, a growth of 11.8% from the March 15th total of 1,870,000 shares. Based on an average daily volume of 651,500 shares, the short-interest ratio is currently 3.2 days.April 14, 2024 | marketbeat.com Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. CGEN Media Mentions By Week CGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEN News Sentiment▼1.100.45▲Average Medical News Sentiment CGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEN Articles This Week▼22▲CGEN Articles Average Week Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Black Diamond Therapeutics News Coherus BioSciences News Inhibrx News iTeos Therapeutics News ORIC Pharmaceuticals News Mereo BioPharma Group News Nuvation Bio News Korro Bio News Neurogene News Q32 Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEN Stock Alerts